VOYA Investment Management
DYN icon

VOYA Investment Management’s Dyne Therapeutics DYN Stock Holding History

VOYA Investment Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Buy
174,457
+87,848
+101% +$1.63M ﹤0.01% 970
2026
Q1 		$1.57M Buy
86,609
+171
+0.2% +$2.95K ﹤0.01% 1294
2025
Q4 		$1.69M Sell
86,438
-12,263
-12% -$232K ﹤0.01% 1281
2025
Q3 		$1.25M Buy
98,701
+45,527
+86% +$519K ﹤0.01% 1403
2025
Q2 		$506K Buy
53,174
+3,388
+7% +$37.3K ﹤0.01% 1891
2025
Q1 		$521K Sell
49,786
-200,017
-80% -$2.86M ﹤0.01% 1855
2024
Q4 		$5.89M Sell
249,803
-5,582
-2% -$165K 0.01% 912
2024
Q3 		$9.17M Sell
255,385
-4,982
-2% -$198K 0.01% 800
2024
Q2 		$9.19M Buy
260,367
+183,433
+238% +$5.33M 0.01% 786
2024
Q1 		$2.18M Buy
76,934
+38,152
+98% +$863K ﹤0.01% 1318
2023
Q4 		$516K Sell
38,782
-33,165
-46% -$324K ﹤0.01% 2059
2023
Q3 		$645K Sell
71,947
-48,909
-40% -$527K ﹤0.01% 1903
2023
Q2 		$1.36M Buy
120,856
+66,591
+123% +$786K ﹤0.01% 1514
2023
Q1 		$625K Buy
54,265
+41,570
+327% +$540K ﹤0.01% 1917
2022
Q4 		$147K Hold
12,695
– – ﹤0.01% 2659
2022
Q3 		$161K Buy
12,695
+997
+9% +$11.4K ﹤0.01% 2669
2022
Q2 		$80K Hold
11,698
– – ﹤0.01% 2670
2022
Q1 		$113K Hold
11,698
– – ﹤0.01% 2495
2021
Q4 		$139K Sell
11,698
-1
-0% -$14 ﹤0.01% 2608
2021
Q3 		$190K Hold
11,699
– – ﹤0.01% 2592
2021
Q2 		$246K Buy
+11,699
New +$220K ﹤0.01% 2485

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VOYA Investment Management's DYN Position: Q2 2026 in Review

VOYA Investment Management increased its Dyne Therapeutics (DYN) stake by 101% in Q2 2026, buying an estimated $1.63M and bringing the position to 174,457 shares worth $3.87M. The position accounts for ﹤0.01% of the portfolio, ranked #970.

VOYA Investment Management first reported a position in DYN in Q2 2021 and has held it in 21 quarters since. The position peaked at $9.19M in Q2 2024. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • VOYA Investment Management held 174,457 shares of Dyne Therapeutics worth $3.87M as of Q2 2026.
  • VOYA Investment Management bought 87,848 Dyne Therapeutics shares in Q2 2026, an estimated $1.63M.
  • Dyne Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #970 holding.
  • VOYA Investment Management first reported a position in Dyne Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • VOYA Investment Management's Dyne Therapeutics position peaked at $9.19M in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.